血液中のバクテロイド.

Susceptibility of Cryptococcus neoformans by the NCCLS microdilution and Etest methods using five defined media.

The Journal of antimicrobial chemotherapy·2000

An outbreak of methicillin-resistant staphylococcus aureus (MRSA) in a dermatology day-care unit.

Clinical and experimental dermatology·1999

Comparison of a new insertion element, IS1407, with established molecular markers for the characterization of Mycobacterium celatum.

International journal of systematic bacteriology·1997

Pilot studies of azithromycin, letrazuril and paromomycin in the treatment of cryptosporidiosis.

International journal of STD & AIDS·1997

A new group (type 3) of Mycobacterium celatum isolated from AIDS patients in the London area.

International journal of systematic bacteriology·1995

Rapid identification of mycobacteria from AIDS patients by capillary electrophoretic profiling of amplified SOD gene.

Clinical molecular pathology·1995

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Design of solid phase microextraction patches for the detection of volatile metabolites associated with Burkholderia cepacia.

Applied microbiology and biotechnology·2026

Bacteremia evaluation with T2 magnetic resonance in the emergency room (BETTER).

Microbiology spectrum·2026

A Fatal Case of Clostridium septicum Mycotic Aortic Aneurysm: The Inadequacy of Thoracic Endovascular Aortic Repair in the Absence of Open Surgical Repair.

Cureus·2026

The power of ten: report from the 10th American Society for Microbiology Conference on Biofilms.

Journal of bacteriology·2026

Resistome, virulome and genomic insights into the silent dissemination of <i>Acinetobacter baumannii</i> during the COVID-19 pandemic in Brazil.

Frontiers in cellular and infection microbiology·2026

Correction: Presence of bacterial DNA in synovial fluid from the temporomandibular joint in patients with temporomandibular joint disorders.

Frontiers in oral health·2026

関連する実験動画

血液中のバクテロイド.

関連する概念動画

Susceptibility of Cryptococcus neoformans by the NCCLS microdilution and Etest methods using five defined media.

An outbreak of methicillin-resistant staphylococcus aureus (MRSA) in a dermatology day-care unit.

Comparison of a new insertion element, IS1407, with established molecular markers for the characterization of Mycobacterium celatum.

Pilot studies of azithromycin, letrazuril and paromomycin in the treatment of cryptosporidiosis.

A new group (type 3) of Mycobacterium celatum isolated from AIDS patients in the London area.

Rapid identification of mycobacteria from AIDS patients by capillary electrophoretic profiling of amplified SOD gene.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Design of solid phase microextraction patches for the detection of volatile metabolites associated with Burkholderia cepacia.

Bacteremia evaluation with T2 magnetic resonance in the emergency room (BETTER).

A Fatal Case of Clostridium septicum Mycotic Aortic Aneurysm: The Inadequacy of Thoracic Endovascular Aortic Repair in the Absence of Open Surgical Repair.

The power of ten: report from the 10th American Society for Microbiology Conference on Biofilms.

Resistome, virulome and genomic insights into the silent dissemination of <i>Acinetobacter baumannii</i> during the COVID-19 pandemic in Brazil.

Correction: Presence of bacterial DNA in synovial fluid from the temporomandibular joint in patients with temporomandibular joint disorders.

関連する実験動画

血液中のバクテロイド.

関連する概念動画

関連記事